Results Interim Reports
- Q1 2022
Key figures
in EUR million Q1 2022 Q1 2021 Sales 444.8 400.4 EBITDA 47.1 47.7 EBIT 20.7 25.0 EBIT margin (in %) 4.7 6.2 Group net income for the year
(earnings after taxes)4.6 12.1 Earnings per share (in EUR) 0.17 0.49 Operating cash flow -27.5 -15.0 Cash flow from operating activities -29.8 -17.6 Cash flow from investing activities -1.5 -38.3 Cash flow from financing activities 27.2 118.0 in EUR million March 31, 2022 December 31, 2021 Total assets 1,939.5 1,857.4 Equity 802.2 787.5 Equity ratio (in %) 41.4 42.4 Working capital 520.8 457.5 Net debt 538.0 504.2 Cash and cash equivalents 132.1 136.3 Portfolio companies
(number as of reporting date)46 46 Segment overview
in EUR million Q1 2022 Q1 2021 Difference
absoluteDifference
in %Construction/Infrastructure Revenue with external third parties 124.3 96.0 28.3 29.5 EBITDA 22.7 18.9 3.8 20.1 Depreciation/amortization -5,0 -4.1 -0.9 -22.0 EBIT 17.7 14.8 2.9 19.6 EBIT margin (in %) 14.2 15.4 -1.2 pp – Investments 1.7 3.4 -1.7 -50.0 Employees 2,333 1,945 388 19.9 Automotive Technology Revenue with external third parties 57.9 69.9 -12.0 -17.2 EBITDA -15.1 -3.1 -12.0 <-100 Depreciation/amortization -8.9 -6.6 -2.3 -34.8 EBIT -24.0 -9.7 -14.3 <-100 EBIT margin (in %) -41.5 -13.9 -27.6 pp – Investments 4.8 6.0 -1.2 -20.0 Employees 2,810 3,199 -389 -12.2 Engineering Revenue with external third parties 109.1 92.6 16.5 17.8 EBITDA 21.0 14.2 6.8 47.9 Depreciation/amortization -5.6 -5.3 -0.3 -5.7 EBIT 15.4 8.9 6.5 73.0 EBIT margin (in %) 14.1 9.6 4.5 pp – Investments 2.3 27.5 -25.2 -91.6 Employees 2,334 2,249 85 3.8 Medical Engineering/Life Science Revenue with external third parties 38.7 35.6 3.1 8.7 EBITDA 5.7 5.8 -0.1 -1.7 Depreciation/amortization -2.6 -2.7 0.1 3.7 EBIT 3.1 3.1 0.0 0.0 EBIT margin (in %) 8.0 8.7 -0.7 pp – Investments 1.3 0.8 0.5 62.5 Employees 1,600 1,606 -6 -0.4 Metals Technology Revenue with external third parties 114.7 106.6 8.1 7.6 EBITDA 15.3 14.0 1.3 9.3 Depreciation/amortization -4.0 -3.8 -0.2 -5.3 EBIT 11.2 10.1 1.1 10.9 EBIT margin (in %) 9.8 9.5 0.3 pp – Investments 1.3 0.7 0.6 85.7 Employees 1,486 1,543 -57 -3.7 - Q2 2022
Key figures
in EUR million Q2 2022 Q2 2021 Sales 500.1 449.9 EBITDA 55.4 54.7 EBIT 30.4 31.3 Group net income for the year (earnings after taxes) 16.1 16.6 Earnings per share (in EUR) 0.59 0.60 Segment overview
in EUR million Q2 2022 Q2 2021 Difference
absoluteDifference
in %Construction/Infrastructure Revenue with external third parties 137.2 120.2 17.0 14.1 EBITDA 26.4 25.7 0.7 2.7 Depreciation/amortization -5.2 -4.9 -0.3 -6.1 EBIT 21.2 20.8 0.4 1.9 EBIT margin (in %) 15.5 17.3 -1.8 pp – Investments 2.9 36.4 -33.5 -92.0 Employees 2,336 2,165 171 7.9 Automotive Technology Revenue with external third parties 65.4 73.7 -8,3 -11.3 EBITDA -10.1 -3.2 -6.9 <-100 Depreciation/amortization -6.4 -6.6 0.2 3.0 EBIT -16.5 -9.8 -6.7 -68.4 EBIT margin (in %) -25.2 -13.3 11.9 pp – Investments 7.3 4.6 2.7 58.7 Employees 2,812 3,308 -496 -15.0 Engineering Revenue with external third parties 138.1 106.1 32.0 30.2 EBITDA 17.2 16.2 1.0 6.2 Depreciation/amortization -6.6 -5.4 -1.2 -22.2 EBIT 10.6 10.8 -0.2 -1.9 EBIT margin (in %) 7.7 10.2 -2.5 pp – Investments 61.5 1.3 60.2 >100 Employees 2,433 2,232 201 9.0 Medical Engineering/Life Science Revenue with external third parties 38.7 37.6 1.1 2.9 EBITDA 4.5 5.0 -0.5 -10.0 Depreciation/amortization -2.6 -2.4 -0.2 -8.3 EBIT 1.9 2.6 -0.7 -26.9 EBIT margin (in %) 4.9 6.9 -2.0 pp – Investments 1.8 5.7 -3.9 -68.4 Employees 1,592 1,612 -20 -1.2 Metals Technology Revenue with external third parties 120.5 112.1 8.4 7.5 EBITDA 19.6 13.3 6.3 47.4 Depreciation/amortization -3.9 -3.8 -0.1 -2.6 EBIT 15.7 9.5 6.2 65.3 EBIT margin (in %) 13.0 8.5 4.5 pp – Investments 1.2 3.3 -2.1 -63.6 Employees 1,497 1,541 -44 -2.9 - H1 2022
Key figures
in EUR million H1 2022 H1 2021 Sales 944.9 850.3 EBITDA 102.5 102.4 EBIT 51.1 56.3 EBIT margin (in %) 5.4 6.6 Group net income for the year (earnings after taxes) 20.7 28.7 Earnings per share (in EUR) 0.76 1.16 Operating cash flow -39.7 22.8 Cash flow from operating activities -50.9 11.4 Cash flow from investing activities -71.5 -89.1 Cash flow from financing activities 101.2 45.7 June 30, 2022 December 31, 2021 Total assets 2,083.2 1,857.4 Equity 801.9 787.5 Equity ratio (in %) 38.5 42.4 Working capital 603.5 457.5 Net debt 662.3 504.2 Cash and cash equivalents 115.3 136.3 Portfolio companies (number as of reporting date) 48 46 Segment overview
in EUR million H1 2022 H1 2021 Difference
absoluteDifference
in %Construction/Infrastructure Revenue with external third parties 261.5 216.2 45.3 21.0 EBITDA 49.1 44.6 4.5 10.1 Depreciation/amortization -10.2 -9.0 -1.2 -13.3 EBIT 38.9 35.6 3.3 9.3 EBIT margin (in %) 14.9 16.5 -1.6 pp – Investments 4.6 39.8 -35.2 -88.4 Employees 2,334 2,055 279 13.6 Automotive Technology Revenue with external third parties 123.3 143.5 -20.2 -14.1 EBITDA -25.1 -6.3 -18.8 <-100 Depreciation/amortization -15.3 -13.2 -2.1 -15.9 EBIT -40.4 -19.5 -20.9 <-100 EBIT margin (in %) -32.8 -13.6 -19.2 pp – Investments 12.1 10.6 1.5 14.2 Employees 2,812 3,253 -441 -13.6 Engineering Revenue with external third parties 247.2 198.8 48.4 24.3 EBITDA 38.2 30.5 7.7 25.2 Depreciation/amortization -12.2 -10.7 -1.5 -14.0 EBIT 26.0 19.8 6.2 31.3 EBIT margin (in %) 10.5 10.0 0.5 pp – Investments 63.8 28.8 35.0 >100 Employees 2,383 2,241 142 6.3 Medical Engineering/Life Science Revenue with external third parties 77.4 73.2 4.2 5.7 EBITDA 10.2 10.9 -0.7 -6.4 Depreciation/amortization -5.2 -5.1 -0.1 -2.0 EBIT 5.0 5.8 -0.8 -13.8 EBIT margin (in %) 6.5 7.9 -1.4 pp – Investments 3.1 6.5 -3.4 -52.3 Employees 1,596 1,609 -13 -0.8 Metals Technology Revenue with external third parties 235.2 218.7 16.5 7.5 EBITDA 34.8 27.2 7.6 27.9 Depreciation/amortization -7.9 -7.6 -0.3 -3.9 EBIT 26.9 19.6 7.3 37.2 EBIT margin (in %) 11.4 9.0 2.4 pp – Investments 2.5 3.9 -1.4 -35.9 Employees 1,492 1,542 -50 -3.2 - Q3 2022
Key figures
in EUR million Q3 2022 Q3 2021 Sales 490.0 446.1 EBITDA 43.6 54.6 EBIT -39.9 22.2 Group net income for the year (earnings after taxes) -50.5 10.5 Earnings per share (in EUR) -1.96 0.39 Segment overview
in EUR million Q3 2022 Q3 2021 Difference
absoluteDifference
in %Construction/Infrastructure Revenue with external third parties 135.5 121.8 13.7 11.2 EBITDA 25.7 23.8 1.9 8.0 Depreciation/amortization -5.0 -5.2 0.2 3.8 EBIT before impairment 20.7 18.6 2.1 11.3 EBIT margin before impairment in % 15.3 15.3 0.0 pp – Impairment -12.7 0.0 -12.7 – EBIT 8.0 18.6 -10.6 -57.0 EBIT margin (in %) 5.9 15.3 -9.4 pp – Investments 4.2 3.6 0.6 16.7 Employees 2,347 2,273 74 3.3 Automotive Technology Revenue with external third parties 66.6 69.5 -2.9 -4.2 EBITDA -26.7 -7.2 -19.5 <-100 Depreciation/amortization -6.1 -14.8 8.7 58.8 EBIT before impairment -32.9 -23.6 -9.3 -39.4 EBIT margin before impairment in % -49.4 -34.0 -15.4 pp – Impairment -18.9 -8.2 -10.7 <-100 EBIT -51.8 -22.0 -29.8 <-100 EBIT margin (in %) -77.8 -31.7 -46.1 pp – Investments 9.4 4.5 4.9 >100 Employees 2,820 3,308 -488 -14.8 Engineering Revenue with external third parties 133.3 113.1 20.2 17.9 EBITDA 23.9 21.7 2.2 10.1 Depreciation/amortization -6.8 -5.7 -1.1 -19.3 EBIT before impairment 17.1 16.0 1.1 6.9 EBIT margin before impairment in % 12.8 14.1 -1.3 pp – Impairment -13.8 0.0 -13.8 – EBIT 3.3 16.0 -12.7 -79.4 EBIT margin (in %) 2.5 14.0 -11.5 pp – Investments 1.4 5.2 -3.8 -73.1 Employees 2,450 2,270 180 7.9 Medical Engineering/Life Science Revenue with external third parties 39.2 37.4 1.8 4.8 EBITDA 5.5 5.7 -0.2 -3.5 Depreciation/amortization -2.6 -2.5 -0.1 -4.0 EBIT before impairment 2.9 3.2 -0.3 -9.4 EBIT margin before impairment in % 7.4 8.6 -1.2 pp – Impairment -11.7 0.0 -11.7 – EBIT -8.8 3.2 -12.0 <-100 EBIT margin (in %) -22.4 8.6 -31.0 pp – Investments 2.2 1.2 1.0 83.3 Employees 1,565 1,616 -51 -3.2 Metals Technology Revenue with external third parties 115.3 104.3 11.0 10.5 EBITDA 16.7 12.0 4.7 39.2 Depreciation/amortization -4.0 -3.9 -0.1 -2.6 EBIT before impairment 14.3 8.1 6.2 76.5 EBIT margin before impairment in % 12.4 7.8 4.6 pp – Impairment -1.6 0.0 -1.6 – EBIT 12.7 8.1 4.6 56.8 EBIT margin (in %) 11.0 7.8 3.2 pp – Investments 3.0 1.8 1.2 66.7 Employees 1,505 1,501 4 0.3 - 9M 2022
Key figures
in EUR million 9M 2022 9M 2021 Sales 1,434.9 1,296.4 EBITDA 146.1 157,1 EBIT before impairment 92.7 86.8 EBIT margin before impairment in % 6.5 6.7 Impairment (SMA a. impairment tests) -81.5 -8.2 EBIT 11.2 78.6 EBIT margin (in %) 0.8 6.1 Group net income for the year (earnings after taxes) -29.8 39.4 Earnings per share (in EUR) -1.13 1.48 Operating cash flow 0.1 74.1 Cash flow from operating activities -13.9 59.8 Cash flow from investing activities -90.4 -105.4 Cash flow from financing activities 98.8 14.4 September 30, 2022 December 31, 2021 Total assets 2,031.1 1,857.4 Equity 761.1 787.5 Equity ratio (in %) 37.5 42.4 Working capital 618.1 457.5 Net debt 646.8 504.2 Cash and cash equivalents 130.8 136.3 Portfolio companies (number as of reporting date) 48 46 Segment overview
in EUR million 9M 2022 9M 2021 Difference
absoluteDifference
in %Construction/Infrastructure Revenue with external third parties 397.0 338.0 59.0 17.5 EBITDA 74.8 68.4 6.4 9.4 Depreciation/amortization -15.2 -14.2 -1.0 -7.0 EBIT before impairment 59.6 54.2 5.4 10.0 EBIT margin before impairment in % 15.0 16.0 -1.0 pp – Impairment -12.7 0.0 -12.7 – EBIT 46.9 54.2 -7.3 -13.5 EBIT margin (in %) 11.8 16.0 -4.2 pp – Investments 8.8 43.4 -34.6 -79.7 Employees 2,339 2,127 212 10.0 Automotive Technology Revenue with external third parties 189.9 213.0 -23.1 -10.8 EBITDA -51.8 -13.6 -38.2 <-100 Depreciation/amortization -18.6 -27.9 9.3 33.3 EBIT before impairment -70.4 -33.3 -37.1 <-100 EBIT margin before impairment in % -37.1 -15.6 -21.5 pp – Impairment -21.8 -8.2 -13.6 <-100 EBIT -92.2 -41.5 -50.7 <-100 EBIT margin (in %) -48.6 -19.5 -29.1 pp – Investments 21.5 15.1 6.4 42.4 Employees 2,814 3,288 -474 -14.4 Engineering Revenue with external third parties 380.5 311.9 68.6 22.0 EBITDA 62.1 52.2 9.9 19.0 Depreciation/amortization -19.0 -16.4 -2.6 -15.9 EBIT before impairment 43.1 35.8 7.3 20.4 EBIT margin before impairment in % 11.3 11.5 -0.2 pp – Impairment -13.8 0.0 -13.8 – EBIT 29.3 35.8 -6.5 -18.2 EBIT margin (in %) 7.7 11.5 -3.8 pp – Investments 65.3 34.0 31.3 92.1 Employees 2,406 2,250 156 6.9 Medical Engineering/Life Science Revenue with external third parties 116.6 110.6 6.0 5.4 EBITDA 15.6 16.7 -1.1 -6.6 Depreciation/amortization -7.7 -7.7 0.0 0.0 EBIT before impairment 7.9 9.0 -1.1 -12.2 EBIT margin before impairment in % 6.8 8.1 -1.3 pp – Impairment -11.7 0.0 -11.7 – EBIT -3.8 9.0 -12.8 <-100 EBIT margin (in %) -3.3 8.1 -11.4 pp – Investments 5.3 7.7 -2.4 -31.2 Employees 1,586 1,611 -25 -1.6 Metals Technology Revenue with external third parties 350.5 323.0 27.5 8.5 EBITDA 53.1 39.2 13.9 35.5 Depreciation/amortization -11.9 -11.5 -0.4 -3.5 EBIT before impairment 41.2 27.7 13.5 48.7 EBIT margin before impairment in % 11.8 8.6 3.2 pp – Impairment -1.6 0.0 -1.6 – EBIT 39.6 27.7 11.9 43.0 EBIT margin (in %) 11.3 8.6 2.7 pp – Investments 5.5 5.7 -0.2 -3.5 Employees 1,496 1,529 -33 -2.2
Results fiscal year 2021
Generate factsheetStatement of income
in EUR million | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
Sales | 1,741.5 | 1,558.6 | 1,742.8 | 1,710.8 | 1,640.6 |
of which domestic | 910.3 | 801.8 | 890.2 | 878.9 | 815.5 |
of which domestic (in %) | 52.3 | 51.4 | 51.1 | 51.4 | 49.7 |
of which abroad | 831.2 | 756.8 | 852.6 | 831.9 | 825.1 |
of which abroad (in %) | 47.7 | 48.6 | 48.9 | 48.6 | 50.3 |
EBITDA | 220.4 | 157.7 | 225.7 | 218.1 | 213.9 |
EBIT before impairments | 123.6 | 65.7 | 135.2 | 150.5 | 151.5 |
EBIT margin before impairments (in %) | 7.1 | 4.2 | 7.8 | 8.8 | 9.2 |
Impairments* | 8.2 | 40.6 | 17.3 | 16.1 | 0.0 |
EBIT | 115.4 | 25.1 | 117.9 | 134.4 | 151.5 |
EBIT margin (in %) | 6.6 | 1.6 | 6.8 | 7.9 | 9.2 |
EBT | 99.1 | 9.6 | 99.0 | 114.7 | 129.3 |
Group net income for the year | 47.6 | -26.9 | 60.1 | 71.2 | 83.1 |
Segment overview
in EUR million | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
Construction/Infrastructure | |||||
Revenue with external third parties | 451.6 | 384.0 | 388.9 | 358.7 | 330.4 |
EBITDA | 89.6 | 79.9 | 77.0 | 60.1 | 57.6 |
Depreciation/amortization | -19.1 | -15.4 | -14.0 | -10.1 | -8.8 |
EBIT | 70.5 | 64.5 | 63.0 | 50.0 | 48.8 |
EBIT margin (in %) | 15.6 | 16.8 | 16.2 | 13.9 | 14.8 |
Investments | 48.6 | 18.1 | 18.8 | 25.5 | 13.4 |
Employees | 2,173 | 1,898 | 1,874 | 1,839 | 1,714 |
Automotive Technology | |||||
Revenue with external third parties | 281.9 | 296.2 | 350.3 | 391.0 | 394.1 |
EBITDA | -21.6 | -26.7 | 9.0 | 28.4 | 36.0 |
Depreciation/amortization | -27.5 | -27.3 | -27.5 | -23.4 | -21.8 |
EBIT before impairment | -49.1 | -54.0 | -18.5 | 5.0 | 14.2 |
EBIT margin before impairment in % | -17.4 | -20.1 | -5.3 | 1.3 | 3.6 |
Impairment | -8.2 | -33.8 | 0.0 | -9.5 | 0.0 |
EBIT | -57.3 | -87.8 | -35.8 | -4.5 | 14.2 |
EBIT margin (in %) | -20.3 | -32.6 | -10.2 | -1.2 | 3.6 |
Investments | 27.7 | 18.0 | 22.8 | 29.5 | 30.3 |
Employees | 3,277 | 3,202 | 3,360 | 3,524 | 3,557 |
Engineering | |||||
Revenue with external third parties | 438.9 | 370.0 | 434.6 | 387.0 | 375.1 |
EBITDA | 79.6 | 53.9 | 73.0 | 64.2 | 64.0 |
Depreciation/amortization | -22.7 | -20.2 | -18.4 | -12.2 | -10.7 |
EBIT before impairment | 56.9 | 33.7 | 54.6 | 52.0 | 53.3 |
EBIT margin before impairment in % | 13.0 | 9.1 | 12.6 | 13.4 | 14.2 |
Impairment | 0.0 | -2.3 | 0.0 | 0.0 | 0.0 |
EBIT | 56.9 | 31.4 | 54.6 | 52.0 | 53.3 |
EBIT margin (in %) | 13.0 | 8.5 | 12.6 | 13.4 | 14.2 |
Investments | 40.9 | 4.1 | 30.9 | 12.0 | 43.4 |
Employees | 2,289 | 2,243 | 2,180 | 2,027 | 1,830 |
Medical Engineering/Life Science | |||||
Revenue with external third parties | 148.7 | 142.1 | 159.7 | 154.3 | 155.2 |
EBITDA | 23.0 | 20.4 | 27.9 | 24.7 | 27.6 |
Depreciation/amortization | -10.9 | -10.2 | -9.3 | -7.4 | -6.8 |
EBIT | 12.1 | 10.2 | 18.6 | 17.3 | 20.8 |
EBIT margin (in %) | 8.1 | 7.2 | 11.6 | 11.2 | 13.4 |
Investments | 11.6 | 6.2 | 4.9 | 8.5 | 7.4 |
Employees | 1,613 | 1,646 | 1,718 | 1,687 | 1,540 |
Metals Technology | |||||
Revenue with external third parties | 420.4 | 393.6 | 409.2 | 420.0 | 385.6 |
EBITDA | 57.9 | 36.9 | 46.1 | 48.5 | 37.7 |
Depreciation/amortization | -15.6 | -18.0 | -20.3 | -13.6 | -13.5 |
EBIT before impairment | 42.3 | 18.9 | 25.8 | 34.9 | 24.2 |
EBIT margin before impairment in % | 10.1 | 4.8 | 6.3 | 8.3 | 6.3 |
Impairment | 0.0 | -4.5 | 0.0 | -6.6 | 0.0 |
EBIT | 42.3 | 14.4 | 25.8 | 28.3 | 24.2 |
EBIT margin (in %) | 10.1 | 3.7 | 6.3 | 6.7 | 6.3 |
Investments | 14.0 | 6.9 | 25.1 | 26.3 | 14.5 |
Employees | 1,520 | 1,616 | 1,687 | 1,602 | 1,538 |
Statement of Cash Flow
in EUR million | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
Operating cash flow | 136.4 | 174.4 | 167.7 | 96.0 | 144.9 |
Cash flow from operating activities | 116.6 | 155.2 | 147.3 | 74.7 | 124.0 |
Cash flow from investing activities | -130.4 | -52.4 | -76.2 | -98.3 | -110.0 |
Cash flow from financing activties | -44.5 | -42.0 | -46.1 | -2.8 | -3.9 |
Cash and cash equivalents | 136.3 | 194.7 | 135.1 | 109.6 | 135.9 |
Statement of Financial Position
in EUR million | 31.12.2021 | 31.12.2020 | 31.12.2019 | 31.12.2018 | 31.12.2017 |
---|---|---|---|---|---|
Total assets | 1,857.4 | 1,728.8 | 1,808.2 | 1,720.0 | 1,653.2 |
Equity | 787.5 | 676.4 | 727.7 | 709.8 | 673.8 |
Equity ratio (in %) | 42.4 | 39.1 | 40.2 | 41.3 | 40.8 |
Equity ratio** (in %) | 6.0 | -4.0 | 8.3 | 10.0 | 12.3 |
Net debt | 504.1 | 518.9 | 546.2 | 482.8 | 389.9 |
Net debt/EBITDA | 2.3 | 3.3 | 2.4 | 2.2 | 1.9 |
Working capital**** | 457.5 | 410.5 | 478.3 | 472.2 | 402.9 |
Gearing***** | 0.6 | 0.8 | 0.8 | 0.7 | 0.6 |
Investments and depreciation/amortization
in EUR million | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
Investments | 142.9 | 53.5 | 107.4 | 102.4 | 111.4 |
of which in company acquisitions | 67.3 | 0.0 | 29.2 | 11.5 | 32.4 |
of which in investments according to the equity method | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 |
of which in intangible assets | 8.9 | 8.4 | 11.0 | 12.0 | 7.7 |
of which in property, plant and equipment | 66.7 | 44.1 | 67.3 | 78.9 | 71.3 |
Depreciation/amortization | -105.0 | -132.6 | -107.8 | -83.7 | -62.4 |
Share
in EUR | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
Number of shares | 26,895,559 | 24,450.509 | 24,450,509 | 24,450,509 | 24,450,509 |
Market capitalization (in EUR million) | 880.8 | 784.9 | 949.9 | 953.6 | 1,454.8 |
Year-end price (XETRA) | 32.75 | 32.10 | 38.85 | 39.00 | 59.50 |
Year-high closing price (XETRA) | 37.30 | 40.40 | 47.45 | 66.00 | 65.10 |
Year-low closing price (XETRA) | 29.40 | 21.40 | 31.45 | 37.65 | 50.48 |
Earnings per share Group | 1.78 | -1.10 | 2.43 | 2.90 | 3.37 |
Cash flow per share Group | 4.43 | 6.35 | 6.02 | 3.05 | 5.07 |
Dividend per share Group****** | 1.05 | 0.80 | 0.80 | 1.50 | 1.50 |
Dividend yield (in %)****** | 3.2 | 2.5 | 2.1 | 3.8 | 2.5 |
Dividend payout ratio (in %)****** | 51.9 | 60.0 | 24.6 | 48.1 | 43.9 |
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Portfolio companies (number as of 31.12.) | 46 | 46 | 47 | 45 | 45 |
Employees within the Group (on average) | 10,910 | 10,644 | 10,856 | 10,714 | 10,210 |